Algo version: 0.98b
Medical Developments is listed at the ASX Exchange
Medical Developments [MVP.AX]
ASX Sector: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Is Medical Developments stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Medical Developments pays dividends. Last time was Friday 17th of April 2020 where the investors holding the stock on Thursday 5th of March 2020 were paid $0.01968254 per share. Over the last 15 times between 2004 and 2020, Medical Developments has paid $0.31738278 with an average of $0.02 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Medical Developments 10 years ago, but if you had invested on Sunday 20th of October 2019 when the price was $5.09, you would have made a loss of $-4.66 per share or -91.51%

No, the average daily trading liquidity for Medical Developments is $150 062 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Medical Developments has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Medical Developments to be medium [0.7 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.